FDA Inspection 1201009 — LifeShare Blood Center

LifeShare Blood Center — FEI 3001632629

The FDA completed an inspection of LifeShare Blood Center on March 10, 2023 in Bossier City, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 10, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bossier City, LA (United States)